Literature DB >> 18384140

Oxidation and nuclear localization of thioredoxin-1 in sparse cell cultures.

Jeanine C Spielberger1, Amie D Moody, Walter H Watson.   

Abstract

Reactive oxygen species (ROS) were once viewed only as mediators of toxicity, but it is now recognized that they also contribute to redox signaling through oxidation of specific cysteine thiols on regulatory proteins. Cells in sparse cultures have increased ROS relative to confluent cultures, but it is not known whether protein redox states are affected under these conditions. The purpose of the present study was to determine whether culture conditions affect the redox state of thioredoxin-1 (Trx1), the protein responsible for reducing most oxidized proteins in the cytoplasm and nucleus. The results showed that Trx1 was more oxidized in sparse HeLa cell cultures than in confluent cells. The glutathione pool was also more oxidized, demonstrating that both of the major cellular redox regulating systems were affected by culture density. In addition, the total amount of Trx1 protein was lower and the subcellular distribution of Trx1 was different in sparse cells. Trx1 in sparse cultures was predominantly nuclear whereas it was predominantly cytoplasmic in confluent cultures. This localization pattern was not unique to HeLa cells as it was also observed in A549, Cos-1 and HEK293 cells. These findings demonstrate that Trx1 is subject to changes in expression, redox state and subcellular localization with changing culture density, indicating that the redox environments of the cytoplasm and the nucleus are distinct and have different requirements under different culture conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18384140     DOI: 10.1002/jcb.21762

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

Review 1.  Redox control systems in the nucleus: mechanisms and functions.

Authors:  Young-Mi Go; Dean P Jones
Journal:  Antioxid Redox Signal       Date:  2010-08-15       Impact factor: 8.401

2.  Salmonella type III secretion effector SlrP is an E3 ubiquitin ligase for mammalian thioredoxin.

Authors:  Joaquín Bernal-Bayard; Francisco Ramos-Morales
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

Review 3.  Peroxiredoxin 1 and its role in cell signaling.

Authors:  Carola A Neumann; Juxiang Cao; Yefim Manevich
Journal:  Cell Cycle       Date:  2009-12-05       Impact factor: 4.534

4.  Increased inflammatory signaling and lethality of influenza H1N1 by nuclear thioredoxin-1.

Authors:  Young-Mi Go; Sang-Moo Kang; James R Roede; Michael Orr; Dean P Jones
Journal:  PLoS One       Date:  2011-04-15       Impact factor: 3.240

5.  TIGAR knockdown radiosensitizes TrxR1-overexpressing glioma in vitro and in vivo via inhibiting Trx1 nuclear transport.

Authors:  Yushuo Zhang; Fei Chen; Guomei Tai; Jiaojiao Wang; Jun Shang; Bing Zhang; Ping Wang; Baoxing Huang; Jie Du; Jiahua Yu; Haowen Zhang; Fenju Liu
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

6.  ITCH regulates oxidative stress induced by high glucose through thioredoxin interacting protein in cultured human lens epithelial cells.

Authors:  Lingfeng Jiang; Wenkai Zhou; Bo Lu; Qichang Yan
Journal:  Mol Med Rep       Date:  2020-09-09       Impact factor: 2.952

Review 7.  Cell stress proteins in atherothrombosis.

Authors:  Julio Madrigal-Matute; Roxana Martinez-Pinna; Carlos Ernesto Fernandez-Garcia; Priscila Ramos-Mozo; Elena Burillo; Jesus Egido; Luis Miguel Blanco-Colio; Jose Luis Martin-Ventura
Journal:  Oxid Med Cell Longev       Date:  2012-06-25       Impact factor: 6.543

8.  The Cellular Thioredoxin-1/Thioredoxin Reductase-1 Driven Oxidoreduction Represents a Chemotherapeutic Target for HIV-1 Entry Inhibition.

Authors:  Kathrin Reiser; Leen Mathys; Sophie Curbo; Christophe Pannecouque; Sam Noppen; Sandra Liekens; Lars Engman; Mathias Lundberg; Jan Balzarini; Anna Karlsson
Journal:  PLoS One       Date:  2016-01-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.